Insiders · Profile

Katzoff David J

Chief Financial Officer at Alzamend Neuro. Filing since 14 Sep 2022. CIK 0001864317

Company
Date
Role
Action
Shares
Amount
Of holding
21 Mar 2025
Chief Financial Officer
Bought
5,000
$5.05K
926%
26 Sep 2023
Chief Financial Officer
Bought
53,000
$10.23K
189%
14 Sep 2022
Chief Financial Officer
Bought
10,000
$11.09K
55.6%
3 decisions on file.